SG Americas Securities, LLC

Broker-Dealer

Position in TRVI — Trevi Therapeutics, Inc.

CIK 1313360 NEW YORK, NY

Position in TRVI

as of Jun 30, 2026 · filed Aug 7, 2026 Compact

Position Value

$117,961

-$216,687 QoQ

Shares Held

6,325

-77.5% QoQ

Ownership

0.004%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#171

of 216 holders

Holding Since

Sep 2023

10 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

SG Americas Securities, LLC holds $1,085,838,933 across 181 Biotechnology names. TRVI ranks #151 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	427,703	$266,689,928
2	VRTX	Vertex Pharmaceuticals Inc / Ma	523,720	$260,147,435
3	URGN	UroGen Pharma Ltd.	2,052,906	$75,546,940
4	CGON	CG Oncology, Inc.	867,465	$61,633,388
5	PTCT	Ptc Therapeutics, Inc.	605,581	$49,397,242
6	ASND	Ascendis Pharma A/S	161,026	$42,948,854
7	RPRX	Royalty Pharma plc	688,590	$38,609,241
8	BNTX	BioNTech SE	347,131	$32,300,539

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$117,961	6,325	-77.5%	Shares	Sole	2026-08-07
2026-03-31	$334,648	28,051	-77.5%	Shares	Sole	2026-04-16
2025-12-31	$1,559,516	124,562	+93.0%	Shares	Sole	2026-01-09
2025-09-30	$590,586	64,545	+161.7%	Shares	Sole	2025-10-23
2025-03-31	$155,117	24,661	-8.0%	Shares	Sole	2025-04-15
2024-12-31	$110,383	26,792	+14.5%	Shares	Sole	2025-01-17
2024-09-30	$78,172	23,405	+60.4%	Shares	Sole	2024-10-03
2024-03-31	$50,342	14,592	-85.1%	Shares	Sole	2024-05-06
2023-12-31	$131,659	98,253	+401.4%	Shares	Sole	2024-01-12
2023-09-30	$42,721	19,597	—	Shares	Sole	2023-10-13
No filing history on record for this holder in this stock.